Survodutide
18032976590@mammoth-biotech.com
Product Description
Basic Info.
Survodutide (also known as BI 456906) is a glucagon receptor/glucagon-like peptide-1 receptor (GCGR/GLP-1R) dual agonist, jointly developed by Boehringer Ingelheim and Zealand Pharma, and is intended to treat metabolic diseases such as obesity and non-alcoholic steatohepatitis.
Survodutide is a drug with an innovative mechanism of action and is expected to become a potential option for the treatment of obesity and metabolic-related diseases. Multiple clinical studies are underway to evaluate its safety and efficacy.
“Strength builds the foundation, and excellent services reach all over the world.”
create win-win situation with customers
We have cooperated with experienced shipping forwarders for many years, they arrange the shipment. No matter by express, by air or by sea, we will track the course of the goods all the way, to make sure goods arrive at you on time and in good condition.
Related Products
Gonadorelin Acetate
Basic Info. Gonadorelin acetate is a synthetic decapeptide that serves as gonadotropin-releasing hormone.analogue.It is used therapeutically under several trade names ,including lutrepules and factrel.The primary targets for gonadotrope ce ...
Triptorelin Acetate/GnRH Triptorelin Selank
Basic Info. Triptorelin is a synthetic decapeptide hormone which falls under the gonadotropin-release hormone agoist untilized as the pamoates or acetate salts. (GnRH) utilized as the pamoates or acetat ...
Tirzepatide
Basic Info. Tirzepatide is a revolutionary medication used primarily for managing weight and blood sugar levels. It works by mimicking two naturally oc ...
Oxytocin Acetate
Basic Info. Oxytocin acetate is a form of the hormone oxytocin, a nonapeptide known for its role in uterine contractions, lactation, and various social behaviors. It's synthesized in the hypothalamus and released i ...
Semaglutide
Basic Info. Semaglutide is a GLP-1 receptor agonist (incretin mimetic) used to treat type 2 diabetes and obesity . It stimulates insulin release , suppresses glucagon secretion , slows ...